Neurocysticercosis and oncogenesis

Archives of Medical Research

Volumn 31, Issue 2, 2000, Pages 151-155

  Del Brutto, Oscar H ^a   Dolezal, Milana ^a   Castillo, Pablo R ^b   García, Héctor H ^c  

^a HOSPITAL LUIS VERNAZA   (Ecuador)

^b MAYO CLINIC   (United States)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Brain tumors; Cysticercosis; Glioma; Neurocysticercosis; Oncogenesis; p53

Indexed keywords

CYTOKINE; NITRIC OXIDE; PROTEIN P53;

ASTROCYTE; BRAIN TUMOR; CARCINOGENESIS; CYSTICERCUS; CYTOKINE RELEASE; DNA DAMAGE; GENE TRANSFER; GLIOMA; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; MALIGNANT TRANSFORMATION; NEUROCYSTICERCOSIS; REVIEW; RISK FACTOR; TUMOR IMMUNITY; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; COMORBIDITY; CYSTICERCUS; DISEASE SUSCEPTIBILITY; GENES, HELMINTH; GLIOMA; HOST-PARASITE RELATIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFLAMMATION; NEOPLASMS; NEUROCYSTICERCOSIS; RISK FACTORS;

EID: 0034603416     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(00)00049-7     Document Type: Review

References (58)

1. Stolley P.D., Lasky T. Johanes Fibiger and his Nobel prize for the hypothesis that a worm causes stomach cancer. Ann Intern Med. 116:1992;765.
2. Ryan P., Hurley S.F., Johnson A.M.et al. Tumors of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol. 22:1993;412.
3. Hayashi K., Ohtsuki Y., Ikehara I.et al. Primary rhabdomyosarcoma combined with chronic paragonimiasis in the cerebrum. a necropsy case and review of the literature Acta Neuropathol (Berl). 72:1986;170.
4. Facer C.A., Playfair J.H.L. Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res. 53:1989;33.
5. Haswell-Elkins M.R., Satarug S., Elkins D.B. Opisthorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma. J Gastroenterol Hepatol. 7:1992;538.
6. Parkin D.M., Ohshima H., Srivatanakul P., Vatanasapt V. Cholangiocarcinoma. epidemiology, mechanisms of carcinogenesis and prevention Cancer Epidemiol Biomarkers Prev. 2:1993;537.
7. Rosenthal L.J., Purtilo D.T. Neoplasms associated with infectious agents. Connor D.H., Chandler F.W., Schwartz D.A., Manz H.J., Lack E.E. Pathology of infectious diseases. Vol. II. 1996;Appleton & Lange, Stanford, CA. 1659.p.
8. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994;54 (Suppl):1929s.
9. Badawi A.F., Mostafa M.H., Probert A., O'Connor P.J. Role of schistosomiasis in human bladder cancer. evidence of association, aetiological factors, and basic mechanisms of carcinogenesis Eur J Cancer Prev. 4:1956;45.
10. Warren W., Biggs P.J., el Baz M., Ghonaim M.A., Stratton M.R., Venitt S. Mutations in the p53 gene in schistosomal bladder cancer. a study of 92 tumors from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumors Carcinogenesis. 16:1995;1181.
11. Del Brutto O.H., Castillo P.R., Mena I.X., Freire A.X. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol. 54:1997;1125.
12. Herrera L.A., Benita-Bordes A., Stelo J., Chávez L., Olvera J., Rascón A., López M., Ostrosky-Wegman P. Possible relationship between neurocysticercosis and hematological malignancies. Arch Med Res. 30:1999;154.
13. Villagrán J., Olvera J.E. Cisticercosis humana, estudio clínico y patológico de 481 casos de autópsia. Patologia. 26:1988;149.
14. Hautecoeur P., Gallois P.H., Brucher J.M., Ovelacq E., Dereux J.F. Association d'une cysticercose cérébrale et d'un gliome multifocal. discussion des interactions Rev Neurol (Paris). 143:1987;844.
15. Agapejev S., Alves A., Zanini M.A., Ueda A.K., Pereira E.M. Oligodendroglioma cistico e positividade das reaçoes para cisticercose. relato de caso Arq Neuropsiquiatr. 50:1992;234.
16. Ridaura-Sánz C. Host response in childhood cysticercosis. Childs Nerv Syst. 3:1987;206.
17. Fain A., Duren P., Fels P. Cysticercose généralizée et plasmocytose médullaire (myelome) associés chez une femme de race Muhutu. Ann Soc Belge Med Trop. 36:1956;239.
18. Tucek P.C., Woodard J.C., Moreland A.F. Fibrosarcoma associated with Cysticercus fasciolaris. Lab Anim Sci. 23:1973;401.
19. Hanes M.A. Fibrosarcomas in two rats arising from hepatic cysts of Cysticercus fasciolaris. Vet Pathol. 32:1995;441.
20. Flisser A., Rivera L., Trueba J.et al. Immunology of human neurocysticercosis. Flisser A., Willms K., LaClette J.P., Larralde C., Ridaura C., Beltrán F. Cysticercosis. present state of knowledge and perspectives:1982;Academic Press, New York. 549.p.
21. Bloom B.R. Games parasites play. how parasites evade immune surveillance Nature. 279:1979;21.
22. Mitchel G.F. Effector cells, molecules and mechanisms in host-protective immunity to parasites. Immunology. 38:1979;209.
23. Nussenzweig R.S. Parasitic disease as a cause of immunosuppression. N Engl J Med. 306:1982;423.
24. Willms K., Merchant L., Arcos L., Sealey M., Díaz de León L. Immunopathology of cysticercosis. Larralde C., Willms K., Ortiz L., Seal M. Molecules, cells and parasites in immunology. 1980;Academic Press, New York. 145.p.
25. Molinari J.L., Tato P., Reynoso O.A., León-Cázeres J.M. Depressive effects of a Taenia solium cysticercus factor on cultured human lymphocytes stimulated with phytohaemaglutination. Ann Trop Med Parasitol. 84:1990;205.
26. Flisser A. Taeniasis and cysticercosis due to Taenia solium. Sun T. Progress in clinical parasitology. 1994;CRC Press, Boca Raton, FL. 77.p.
27. Del Brutto O.H., Sotelo J., Román G.C. Neurocysticercosis. A clinical handbook. 1998;Swets & Zeitlinger Publishers, Lisse.
28. White A.C. Jr., Tato P., Molinari J.L. Host-parasite interactions in Taenia solium cysticercosis. Infect Ag Dis. 1:1992;185.
29. White A.C. Jr., Robinson P., Kuhn R. Taenia-solium cysticercosis. host-parasite interactions and the immune response Chem Immunol. 66:1997;209.
30. Gitter B.D., McCormick S.L., Damian R.T. Murine alloantigen acquisition by Schistosoma mansoni. presence of H-2K determinants on adult worms and failure of allogenic lymphocytes to recognize acquired MHC gene products on schistosomula J Parasitol. 68:1982;513.
31. Simpson A.J.G., Singer D., McCutchan T.F., Sacks D.L., Sher A. Evidence that schistosome MHC antigens are not synthesized by the parasite but are acquired from the host as intact glycoproteins. J Immunol. 131:1983;962.
32. Herrera L.A., Santiago P., Rojas G.et al. Immune response impairment, genotoxicity and morphological transformation induced by Taenia solium metacestode. Mutat Res. 305:1994;223.
33. Flisser A., Woodhouse E., Larralde C. Human cysticercosis. antigens, antibodies and non-responders Clin Exp Immunol. 39:1980;27.
34. Plancarte A., Flisser A., Larralde C. Fibronectin-like properties of antigen B from cysticerci of Taenia solium. Flisser A., Willms K., LaClette J.P., Larralde C., Ridaura C., Beltrán F. Cysticercosis. present state of knowledge and perspectives:1982;Academic Press, New York. 453.p.
35. Laclette J.P., Shoemaker C.B., Richter D.et al. Paramyosin inhibits complement C1. J Immunol. 148:1992;124.
36. Thussu A., Sehgal S., Sharma M., Lal V., Sawhney I.M., Prabhakar S. Comparison of cellular responses in single- and multiple-lesion neurocysticercosis. Ann Trop Med Parasitol. 91:1997;627.
37. Dietrich P.-Y., Walker P.R., Saas P., de Tribolet N. Central nervous system tumors and the immune system. Antel J., Birnbaum G., Hartung H.-P. Clinical neuroimmunology. 1998;Blackwell Science, Inc, Malden, MA. 228.p.
38. Young H.F., Sakalas R., Kaplan A.M. Inhibition of cell mediated immunity in patients with brain tumors. Surg Neurol. 5:1976;19.
39. Miescher S., Whiteside T.L., Carrel S., von Fliedner V. Functional properties of tumor infiltrating and blood lymphocytes in patients with solid tumors. effects of tumor cells and their supernatants on proliferative responses to lymphocytes J Immunol. 136:1986;1899.
40. Lassam N., Jay G. Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcriptional initiation. J Immunol. 143:1989;3792.
41. Schneider J., Hofman F.M., Apuzzo M.L.J., Hinton D.R. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg. 77:1992;265.
42. Herrera L.A., Ostrosky-Wegman P., Montero R., Rojas E., Gonsebatt M.E., Schiffmann D. Evaluation of the carcinogenic and genotoxic potential of praziquantel in the Syrian hamster embryo cell transformation assay. Mutat Res. 305:1994;175.
43. Rolfs A., Mühlschlegel F., Jansen-Rosseck R.et al. Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology. 45:1995;532.
44. Goff L.J., Coleman A.W. Transfer of nuclei from a parasite to its host. Proc Natl Acad Sci USA. 81:1984;5420.
45. Howell M.J. Gene exchange between hosts and parasites. Int J Parasitol. 15:1985;597.
46. Montero R., Flisser A., Madrazo I., Cuevas C., Ostrosky-Wegman P. Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. Mutat Res. 305:1994;181.
47. Laclette J.P., Merchant M.T., Damián R.T., Willms K. Crystals of virus-like particles in the metacestode of Taenia solium and T. crassiceps. J Invert Pathol. 56:1990;215.
48. Diamond L.S., Mattern C.F.T., Bartgis I.L. Viruses of Entamoeba histolytica. I. Identification of transmissible virus-like agents. J Virol. 9:1972;326.
49. Mueller J.F., Strano A.J. Sparganum proliferum, a sparganum infected with a virus? J Parasitol. 60:1974;15.
50. Byram J.E., Ernst S.C., Lumsden R.D., Sogandares-Bernal F. Viruslike inclusions in the cecal epithelial cells of Paragonimus kellicotti (digenea, troglotrematidae). J Parasitol. 61:1975;253.
51. Jacobson S., Biddison W.E. Major histocompatibility complex molecules as virus receptors. Immunol Today. 5:1984;262.
52. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711.
53. Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11:1997;443.
54. Hughes P.E., Alexi T., Schreiber S.S. A role for the tumor suppressor gene p53 in regulating neronal apoptosis. Neuroreport. 8(15):1997;V.
55. Bhattacharjee M.B., Bruner J.B. p53 Protein in pediatric malignant astrocytomas. a study of 21 patients J Neuroncol. 32:1997;225.
56. Louis D.N. A molecular genetic model of astrocytoma histopathology. Brain Pathol. 7:1997;755.
57. von Eckardstein K., Gries H., Bolik E., Cervos-Navarro J., Tschairkin I.N., Patt S. p53 Mutations and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry. Histol Histopathol. 12:1997;611.
58. Fueyo J., Gómez-Manzano C., Yung A., Kyritsis A.P. The functional role of tumor suppressor genes in gliomas. Clues for future therapeutic strategies. Neurology. 51:1998;1250.